NatiMab Therapeutics Company
NatiMab Therapeutics identifies and develops human antibodies (Abs) for the therapy and diagnosis of infectious diseases and cancer.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Metropolitan, Michigan, United States
Founded Date:
2008
Employees Number:
11-50
Register and Claim Ownership